AMC: No Time To Celebrate

Summary
- Management details two strong movie releases.
- Q3 box office numbers plunge over 2019 levels.
- Shareholders should just approve share count increase.
Massimo Giachetti/iStock Editorial via Getty Images
In the beginning of September, I detailed how things weren't looking good for theater chain AMC Entertainment (NYSE:AMC). The first two months of Q3 were not looking good for the domestic box office, and coronavirus cases were still rising thanks to the Delta variant. We're now in the final quarter of the year, and despite management celebrating two big movie releases, the numbers still paint a very grim picture.
Monday morning, AMC came out with a press release highlighting some past weekend company stats. Thanks to Venom: Let There Be Carnage in the US and No Time To Die (the latest James Bond movie) in the UK, the company saw its best performance since the start of the pandemic. CEO Adam Aron celebrated this milestone and took a shot at the company's skeptics:
Aron added, “The success of these two new blockbuster movies, and of our theatres both at home and abroad, demonstrates the huge pent-up demand we see in moviegoers who are ever so eager to return to movie theatres. To the self-proclaimed sages who routinely and mindlessly predict the demise of cinemas, it is my view that it is simply wrong to underestimate the enormous consumer appeal and resilience of movie theatres.”
It was rather obvious that at some point, moviegoers would return. Theaters were not going to remain empty forever, but pandemic fears and a shift to some movies being sent directly to streaming services have not helped. The problem for AMC is that before this major weekend, the domestic box office had another horrible quarter in Q3. Take a look at the table below showing a comparison of movie grosses as compared to their 2019 counterparts.
(Source: Box Office Mojo stats, seen here)
I bring up these numbers again because AMC management is on the record saying it will get to positive theater level cash flow in Q4 with a domestic cumulative box office this year of $5.2 billion. Through the first nine months of this year, Box Office Mojo pegged the total number at $2.4 billion. This means that the final three months of this year need $2.8 billion in movie grosses to hit that 2021 yearly mark.
In Q4 2019, the domestic box office total was just under $2.89 billion. For this year to then hit the $5.2 billion number, we can only see Q4 this year down 3.2% as compared to Q4 2019. How is that going to be possible when we just came off a September that was down nearly 47% over 2019 levels, and a more than 51% drop for all of Q3? Don't forget that AMC has raised prices quite a bit since 2019, so actual attendance numbers are actually even weaker than gross ticket sales numbers. That provides other headwinds like reduced concession sales, which are the higher margin part of the business.
Venom and No Time to Die will help the situation a bit, and AMC pointed to movies like West Side Story and Spiderman still coming out this year. The problem is that Q4 2019 had blockbusters like Joker, Frozen II, and Star Wars: Episode IX - The Rise of Skywalker. Even if the international business does fairly well and the domestic box office doesn't completely stink in Q4, I just don't see how AMC gets anywhere near positive theater level free cash flow during the current quarter.
The company may get some further concessions from landlords, but it still is several billion in the hole when it comes to its cash position. Last week's small debt repurchase will reduce future interest expenses, but that took away $41 million plus from the current cash position which will be shrinking moving forward. With Q1 usually being a seasonally weak quarter, there's no guarantee currently that AMC can get to theater level positive cash flow in early 2022. Remember, that metric excludes a bunch of corporate level expenses, which means getting to company wide positive free cash flow is still a major unknown.
I mentioned in a previous article that the stock's price to sales multiple had expanded roughly 30 times over since Covid began, and obviously the valuation here is extreme. While the average price target on the street has roughly tripled from its pandemic low, the current value of $5.44 still implies massive downside from current levels. Shares still go for more than 3.8 times expected revenues for 2023, as compared to the 0.14 times 2019 sales they finished trading that year at, and that two years out analyst average estimate includes revenues more than doubling from this year's expected level.
In the end, AMC may be celebrating a couple of good movie starts, but the overall box office remains quite weak. It will take a massive Q4 for the company to get to where it needs to be for positive theater level cash flow, something that seems nearly impossible given Q3 box office grosses. I'm not here today to say that AMC is going bankrupt, but the company will need additional capital moving forward. Shareholders will likely need to give in and accept some dilution next year by approving an increase in the share count, or they will be helping to speed up the potential demise of this name.
This article was written by
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Investors are always reminded that before making any investment, you should do your own proper due diligence on any name directly or indirectly mentioned in this article. Investors should also consider seeking advice from a broker or financial adviser before making any investment decisions. Any material in this article should be considered general information, and not relied on as a formal investment recommendation.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Recommended For You
Comments (93)








Medium target: $125/share (Elliot Wave theory)
High target: $260/share (resistance)The latest technical graph says $AMC will oscillate between $29/share and $47/share till about November 6 (one month) and then surge to $335/share by December. www.youtube.com/...










